The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer.
Melosky B, Juergens RA, Banerji S, Sacher A, Wheatley-Price P, Snow S, Tsao MS, Leighl NB, Martins I, Cheema P, Liu G, Chu QSC.
Melosky B, et al. Among authors: liu g.
Ther Adv Med Oncol. 2025 Jan 7;17:17588359241308784. doi: 10.1177/17588359241308784. eCollection 2025.
Ther Adv Med Oncol. 2025.
PMID: 39776537
Free PMC article.
Review.